Literature DB >> 15084635

Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency.

Tracy L Breen, Elizabeth Shane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15084635     DOI： 10.1200/JCO.2004.99.013

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  Hyperparathyroidism secondary to zoledronic acid infusion: case report.

Authors:  Meral Sayin; Gozde Yazici
Journal:  Support Care Cancer       Date:  2009-02-10       Impact factor: 3.603

Review 2.  Vitamin D in organ transplantation.

Authors:  E M Stein; E Shane
Journal:  Osteoporos Int       Date:  2011-01-05       Impact factor: 4.507

3.  Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort Study.

Authors:  Hemin Lee; Yinzhu Jin; Miin Roh; Theodore N Tsacogianis; Sangshin Park; Nam-Kyong Choi; Seoyoung C Kim
Journal:  Drugs Aging       Date:  2020-04       Impact factor: 3.923

4.  Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.

Authors:  Elizabeth Shane; Adi Cohen; Emily M Stein; Donald J McMahon; Chiyuan Zhang; Polly Young; Kavita Pandit; Ronald B Staron; Elizabeth C Verna; Robert Brown; Susan Restaino; Donna Mancini
Journal:  J Clin Endocrinol Metab       Date:  2012-09-28       Impact factor: 5.958

5.  Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.

Authors:  Karen A Autio; Azeez Farooki; Ilya G Glezerman; Amelia Chan; Coursen W Schneider; Hallie C Barr; Brian M Seyboth; Lewis J Kampel; Daniel C Danila; Dana E Rathkopf; Susan F Slovin; Howard I Scher; Michael J Morris
Journal:  Clin Genitourin Cancer       Date:  2014-11-22       Impact factor: 2.872

6.  Severe vitamin D deficiency among heart and liver transplant recipients.

Authors:  Emily M Stein; Adi Cohen; Matthew Freeby; Halley Rogers; Shannon Kokolus; Vanessa Scott; Donna Mancini; Susan Restaino; Robert Brown; Donald J McMahon; Elizabeth Shane
Journal:  Clin Transplant       Date:  2009-04-23       Impact factor: 2.863

7.  Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementation.

Authors:  Joseph R Tucci; Henry G Bone; Guoqin Su; Monique Tan; Zafer E Ozturk; Paul Aftring
Journal:  Ther Adv Endocrinol Metab       Date:  2015-08       Impact factor: 3.565

8.  Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.

Authors:  D Generali; A Dovio; M Tampellini; M Tucci; S Tedoldi; M Torta; S Bonardi; G Allevi; S Aguggini; M Milani; A L Harris; A Bottini; L Dogliotti; A Angeli; A Berruti
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

Review 9.  Cholecalciferol and Cancer: Is It a Big D3-eal?

Authors:  Rita Wickham
Journal:  J Adv Pract Oncol       Date:  2012-07

10.  Hypercalcemia of Malignancy and Colorectal Cancer.

Authors:  Rodolfo J Galindo; Isabela Romao; Ageliki Valsamis; Stuart Weinerman; Yael Tobi Harris
Journal:  World J Oncol       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.